Besides, both low HDL-c and LCAT concentration predicted disease progression in diabetic CKD patients (97 out of 164 from the nefroPLIC cohort) and renal function worsening in non-diabetic subjects (153 out of 165 from the PLIC cohort) (Table S7). Here, LCAT is linked to chronic kidney disease.